Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
Key Highlights
- ➤Philips launches HyperVue Integrated System commercially in the U.S.
- ➤HyperVue combines DeepOCT+NIRS imaging and X1-FFR physiology in one platform.
- ➤Permanent installation eliminates mobile-system setup and connection steps per procedure.
- ➤X1-FFR uses one angiographic view to provide FDA-cleared FFR values.
- ➤Philips will showcase HyperVue Integrated and IntraSight Plus at TCT 2026.
Expert Statements
Stacy Beske, Business Leader, Image Guided Therapy Devices at Philips
“Every procedure is an opportunity to help a patient return to a fuller life, and physicians need technology that supports confident clinical decisions without adding unnecessary complexity or time.”
Stacy Beske, Business Leader, Image Guided Therapy Devices at Philips
“For advanced intravascular imaging to become part of everyday practice, it has to fit naturally into the high-volume workflow of the interventional suite. Part of what Philips will showcase at TCT is how this approach extends across our portfolio, bringing imaging, physiology and procedural guidance closer together so physicians can access the information they need throughout the PCI procedure.”
Richard Shlofmitz, MD, Chief of Cardiology, St. Francis Hospital & Heart Center, Catholic Health
“In a high-volume cath lab, imaging technology needs to be readily available, simple to operate and easy to use at the point of care.”
Richard Shlofmitz, MD, Chief of Cardiology, St. Francis Hospital & Heart Center, Catholic Health
“We were encouraged by the HyperVue technology and look forward to continuing our collaboration with Philips to explore how a more integrated workflow can support efficient, patient-focused care.”
* New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for efficient cath lab workflows * At TCT 2026, Philips will showcase its broader full picture portfolio, bringing together imaging, physiology and procedural guidance Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System(1), a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiology assessment. It is designed to keep advanced coronary imaging and physiology tools connected and readily available in the interventional suite. The system will be showcased at TCT 2026 in San Diego, California, October 31–November 3, alongside Philips’ broader portfolio of imaging, physiology and procedural guidance solutions for precision PCI.
Get started
Create a free account to read the full story.